Atlas Trials

Zhu Xiaofan

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zhu Xiaofan

RecordFirmDate
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ (NCT06355739)Zhu Xiaofan2024-02-01

Track Zhu Xiaofan automatically

Every clearance here is in the API, with alerts when new ones post.